Showing posts with label Sunovion Receives FDA Approval for Lonhala Magnair (glycopyrrolate) Inhalation Solution to Treat COPD. Show all posts
Showing posts with label Sunovion Receives FDA Approval for Lonhala Magnair (glycopyrrolate) Inhalation Solution to Treat COPD. Show all posts
Monday, December 18, 2017

Sunovion Receives FDA Approval for Lonhala Magnair (glycopyrrolate) Inhalation Solution to Treat COPD

›
In continuation of my update on glycopyrrolate Sunovion Pharmaceuticals Inc. (Sunovion) today announced that the U.S. Food and Drug Admi...